CA
PBH icon

Continuum Advisory’s Prestige Consumer Healthcare PBH Stock Holding History

Continuum Advisory’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8
Closed -$625 – 1861
2024
Q4 		$625 Hold
8
– – ﹤0.01% 1700
2024
Q3 		$662 Buy
+8
New +$567 ﹤0.01% 1725

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Continuum Advisory's PBH Position: Q1 2025 in Review

Continuum Advisory sold out of Prestige Consumer Healthcare (PBH) in Q1 2025, closing a stake of 8 shares — an estimated $625 sold.

Continuum Advisory first reported a position in PBH in Q3 2024 and held it in 2 quarters. The position peaked at $662 in Q3 2024. 359 funds tracked by Wall St. Rank hold PBH as of Q1 2025.

  • Continuum Advisory reported no remaining Prestige Consumer Healthcare position as of Q1 2025 after selling out during the quarter.
  • Continuum Advisory sold 8 Prestige Consumer Healthcare shares in Q1 2025, an estimated $625.
  • Continuum Advisory first reported a position in Prestige Consumer Healthcare in Q3 2024 and held it in 2 quarters.
  • Continuum Advisory's Prestige Consumer Healthcare position peaked at $662 in Q3 2024.
  • 359 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2025.

Based on Continuum Advisory's 13F filing for Q1 2025, filed 23 Apr 2025.